EXHIBIT 10.1 ------------ AGREEMENT AND PLAN OF MERGERMerger Agreement • February 4th, 2002 • Impath Inc • Services-medical laboratories • New York
IMPATH INC. andRights Agreement • July 23rd, 2002 • Impath Inc • Services-medical laboratories • Delaware
IMPATH INC.Underwriting Agreement • February 17th, 1998 • Impath Inc • Services-medical laboratories • New York
BY AND AMONG IMPATH INC.,Asset Purchase Agreement • March 4th, 2004 • Impath Inc • Services-medical laboratories • New York
Exhibit 10.19 [Conformed Copy] STANDARD FORM OF LOFT LEASE The Real Estate Board of New York, Inc. Agreement of Lease, made as of this 26th day of June 1997, between INTERNATIONAL FLAVORS & FRAGRANCES INC., a corporation organized under the laws of...Lease Agreement • March 10th, 1998 • Impath Inc • Services-medical laboratories
JOINT FILING AGREEMENTJoint Filing Agreement • October 3rd, 2003 • Impath Inc • Services-medical laboratories
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13G (including amendments thereto) with regard to the common stock of IMPATH Inc., a Delaware corporation, and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of October 3, 2003.
December 12, 1997Stock Option Agreement • March 10th, 1998 • Impath Inc • Services-medical laboratories • New York
December 12, 1997Merger Agreement • March 10th, 1998 • Impath Inc • Services-medical laboratories • New York
ContractChange of Control Agreement • August 14th, 2002 • Impath Inc • Services-medical laboratories
ContractCredit Agreement • April 1st, 2002 • Impath Inc • Services-medical laboratories
FIRST AMENDATORY AGREEMENT TO CREDIT AGREEMENT THIS FIRST AMENDATORY AGREEMENT TO CREDIT AGREEMENT made as of the 30th of September, 2001 by and among IMPATH INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and IMPATH PREDICTIVE ONCOLOGY, INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019 and IMPATH-BIS INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and MEDICAL REGISTRY SERVICES, INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and IMPATH-BCP., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and IMPATH-PCRL INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and IMPATH-HDC, INC., a Delaware corporation with its chief exec
ContractEmployment Agreement • April 15th, 2003 • Impath Inc • Services-medical laboratories
Exhibit 10.35 Dear Rich, Your January 9, 2001 agreement (the “Original Agreement”) with IMPATH Inc. (the “Company”) contained certain provisions with regard to a change in control of the Company and severance. This letter sets forth revised terms and is intended to modify the terms of the Original Agreement. The third paragraph of the Original Agreement is amended and replaced in its entirety as follows:
ContractCredit Agreement • April 15th, 2003 • Impath Inc • Services-medical laboratories
Exhibit 10.37 FOURTH AMENDATORY AGREEMENT AND WAIVER TO CREDIT AGREEMENT THIS FOURTH AMENDATORY AGREEMENT AND WAIVER TO CREDIT AGREEMENT (this “Amendment”) made as of the 31st day of March, 2003 by and among IMPATH INC. (“Parent”), IMPATH PREDICTIVE ONCOLOGY, INC., IMPATH-BIS INC., MEDICAL REGISTRY SERVICES, INC., IMPATH-BCP, INC., IMPATH-PCRL INC., IMPATH-HDC, INC., IMPATH INFORMATION SERVICES, INC., TAMTRON CORPORATION and IMPATH-CSL INC. (each of the foregoing is referred to herein individually as a “Borrower” and collectively as the “Borrowers”), FLEET NATIONAL BANK (“Fleet”), THE BANK OF NEW YORK (“BNY”), KEY CORPORATE CAPITAL INC. (“Key”) and BANK LEUMI USA (“Leumi;” Fleet, BNY, Key and Leumi, together with each of their successors and assigns, are referred to herein individually as a “Lender” and collectively as the “Lenders”), FLEET NATIONAL BANK, as Issuing Lender and FLEET NATIONAL BANK, acting in the manner and to the extent described in Article IX of the Credit Agreement
EXHIBIT 10.1 REVOLVING CREDIT AND GUARANTEE AGREEMENTRevolving Credit and Guarantee Agreement • October 8th, 2003 • Impath Inc • Services-medical laboratories • New York
ContractCredit Agreement • April 1st, 2002 • Impath Inc • Services-medical laboratories • New York
Exhibit 10.30 SECOND AMENDATORY AGREEMENT TO CREDIT AGREEMENT THIS SECOND AMENDATORY AGREEMENT TO CREDIT AGREEMENT (this “Amendment”) made as of the 16th of January, 2002 by and among IMPATH INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and IMPATH PREDICTIVE ONCOLOGY, INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019 and IMPATH-BIS INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and MEDICAL REGISTRY SERVICES, INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and IMPATH-BCP, INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and IMPATH-PCRL INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and IMPATH-HDC, INC., a De
December 12, 1997Merger Agreement • March 10th, 1998 • Impath Inc • Services-medical laboratories • New York
ContractCredit Agreement • April 1st, 2002 • Impath Inc • Services-medical laboratories • New York
Exhibit 10.28 CREDIT AGREEMENT CREDIT AGREEMENT dated as of June 4, 2001 among IMPATH INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019, and IMPATH PREDICTIVE ONCOLOGY, INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019 and IMPATH-BIS INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019 and MEDICAL REGISTRY SERVICES, INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019 and IMPATH-BCP INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019 and IMPATH-PCRL INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019 and IMPATH-HDC, INC., a Delaware corporation with its chief executive office at 521 West 57th Street, New York, New York 10019 and IMPATH
ContractCredit Agreement • November 14th, 2002 • Impath Inc • Services-medical laboratories
EXHIBIT 10.33 THIRD AMENDATORY AGREEMENT TO CREDIT AGREEMENT, JOINDER AND ASSIGNMENT AGREEMENT THIS THIRD AMENDATORY AGREEMENT TO CREDIT AGREEMENT, JOINDER AND ASSIGNMENT AGREEMENT (this “Amendment”) made as of the 17th day of October, 2002 by and among IMPATH INC. (“Parent”), IMPATH PREDICTIVE ONCOLOGY, INC., IMPATH-BIS INC., MEDICAL REGISTRY SERVICES, INC., IMPATH-BCP, INC., and IMPATH-PCRL INC., IMPATH-HDC, INC., IMPATH INFORMATION SERVICES, INC., and TAMTRON CORPORATION (each of the foregoing is referred to herein individually as a “Current Borrower” and collectively as the “Current Borrowers”), IMPATH-CSL INC. (“CSL”) (the Current Borrowers and CSL are referred to herein individually as a “Borrower” and collectively as the “Borrowers”), FLEET NATIONAL BANK (“Fleet”), THE BANK OF NEW YORK (“BNY”), KEY CORPORATE CAPITAL INC. (“Key;” Fleet, BNY and Key are referred to herein individually as a “Current Lender” and collectively as the “Current Lenders”), BANK LEUMI USA (the “New Lend
